ENGAGE (Study 301)
E133124
UNEXPLORED
ENGAGE (Study 301) is a large Phase 3 clinical trial designed to evaluate the efficacy and safety of the anti-amyloid monoclonal antibody aducanumab (Aduhelm) in patients with early Alzheimer’s disease.
Referenced by (1)
| Subject (surface form when different) | Predicate |
|---|---|
|
Aduhelm
→
|
clinicalTrial |